RankingsPricing
  1. JP-listed companies
  2. WAKAMOTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Marketable securities, non-current

WAKAMOTO PHARMACEUTICAL CO.,LTD.【JP:4512】

Market cap
¥10.4B
P/E ratio
51.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 20251,848-24.33%
Mar 31, 20242,442-1.66%
Mar 31, 20232,483+20.18%
Mar 31, 20222,066-16.21%
Mar 31, 20212,466+2.27%
Mar 31, 20202,411-8.47%
Mar 31, 20192,634-6.75%
Mar 31, 20182,825+8.85%
Mar 31, 20172,595-4.64%
Mar 31, 20162,722-4.98%
Mar 31, 20152,864

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)